BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28034873)

  • 1. An incomplete trafficking defect to the cell-surface leads to paradoxical thrombocytosis for human and murine MPL P106L.
    Favale F; Messaoudi K; Varghese LN; Boukour S; Pecquet C; Gryshkova V; Defour JP; Albu RI; Bluteau O; Ballerini P; Leverger G; Plo I; Debili N; Raslova H; Favier R; Constantinescu SN; Vainchenker W
    Blood; 2016 Dec; 128(26):3146-3158. PubMed ID: 28034873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The thrombopoietin receptor P106L mutation functionally separates receptor signaling activity from thrombopoietin homeostasis.
    Stockklausner C; Klotter AC; Dickemann N; Kuhlee IN; Duffert CM; Kerber C; Gehring NH; Kulozik AE
    Blood; 2015 Feb; 125(7):1159-69. PubMed ID: 25538044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis.
    Lannutti BJ; Epp A; Roy J; Chen J; Josephson NC
    Blood; 2009 Feb; 113(8):1778-85. PubMed ID: 18796624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis.
    Marty C; Pecquet C; Nivarthi H; El-Khoury M; Chachoua I; Tulliez M; Villeval JL; Raslova H; Kralovics R; Constantinescu SN; Plo I; Vainchenker W
    Blood; 2016 Mar; 127(10):1317-24. PubMed ID: 26608331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Thrombopoietin/Mpl Signaling in Adult Hematopoiesis Identifies New Candidates for Hematopoietic Stem Cell Maintenance.
    Kohlscheen S; Wintterle S; Schwarzer A; Kamp C; Brugman MH; Breuer DC; Büsche G; Baum C; Modlich U
    PLoS One; 2015; 10(7):e0131866. PubMed ID: 26147434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro106Leu MPL mutation is associated with thrombocytosis and a low risk of thrombosis, splenomegaly and marrow fibrosis.
    Alzahrani M; Al Turki S; Al Rajban W; Alshalati F; Almodaihsh F; Abuelgasim KA; Alahmari B; Al Bogami T; Ali O; Al Harbi T; AlBalwi MA; Alotaibi M; Aleem A; Al Asker A; Al Mugairi A
    Platelets; 2022 Nov; 33(8):1220-1227. PubMed ID: 35791502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.
    Deutsch VR; Tomer A
    Br J Haematol; 2013 Jun; 161(6):778-93. PubMed ID: 23594368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes.
    Tiedt R; Coers J; Ziegler S; Wiestner A; Hao-Shen H; Bornmann C; Schenkel J; Karakhanova S; de Sauvage FJ; Jackson CW; Skoda RC
    Blood; 2009 Feb; 113(8):1768-77. PubMed ID: 18845793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial thrombocytosis caused by the novel germ-line mutation p.Pro106Leu in the MPL gene.
    El-Harith el-HA; Roesl C; Ballmaier M; Germeshausen M; Frye-Boukhriss H; von Neuhoff N; Becker C; Nürnberg G; Nürnberg P; Ahmed MA; Hübener J; Schmidtke J; Welte K; Stuhrmann M
    Br J Haematol; 2009 Jan; 144(2):185-94. PubMed ID: 19036112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia.
    Liu K; Martini M; Rocca B; Amos CI; Teofili L; Giona F; Ding J; Komatsu H; Larocca LM; Skoda RC
    Haematologica; 2009 Oct; 94(10):1368-74. PubMed ID: 19608689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation.
    Besancenot R; Roos-Weil D; Tonetti C; Abdelouahab H; Lacout C; Pasquier F; Willekens C; Rameau P; Lecluse Y; Micol JB; Constantinescu SN; Vainchenker W; Solary E; Giraudier S
    Blood; 2014 Sep; 124(13):2104-15. PubMed ID: 25143485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary erythrocytosis, thrombocytosis and neutrophilia.
    Hong WJ; Gotlib J
    Best Pract Res Clin Haematol; 2014 Jun; 27(2):95-106. PubMed ID: 25189721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary thrombocythemia due to splicing donor site mutation of THPO in a Japanese family.
    Kimura H; Onozawa M; Hashiguchi J; Hidaka D; Kanaya M; Matsukawa T; Okada H; Kondo T; Matsuno Y; Teshima T
    Ann Hematol; 2024 Jan; 103(1):89-96. PubMed ID: 37962621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice.
    Lorenz V; Ramsey H; Liu ZJ; Italiano J; Hoffmeister K; Bihorel S; Mager D; Hu Z; Slayton WB; Kile BT; Sola-Visner M; Ferrer-Marin F
    Thromb Haemost; 2017 Dec; 117(12):2322-2333. PubMed ID: 29212120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting Megakaryopoiesis.
    Plo I; Bellanné-Chantelot C; Mosca M; Mazzi S; Marty C; Vainchenker W
    Front Endocrinol (Lausanne); 2017; 8():234. PubMed ID: 28955303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diurnal expression of the thrombopoietin gene is regulated by CLOCK.
    Tracey CJ; Pan X; Catterson JH; Harmar AJ; Hussain MM; Hartley PS
    J Thromb Haemost; 2012 Apr; 10(4):662-9. PubMed ID: 22284746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia.
    Wiestner A; Schlemper RJ; van der Maas AP; Skoda RC
    Nat Genet; 1998 Jan; 18(1):49-52. PubMed ID: 9425899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-Cbl regulates c-MPL receptor trafficking and its internalization.
    Märklin M; Tandler C; Kopp HG; Hoehn KL; Quintanilla-Martinez L; Borst O; Müller MR; Saur SJ
    J Cell Mol Med; 2020 Nov; 24(21):12491-12503. PubMed ID: 32954656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia in a Polish family.
    Liu K; Kralovics R; Rudzki Z; Grabowska B; Buser AS; Olcaydu D; Gisslinger H; Tiedt R; Frank P; Okoñ K; van der Maas AP; Skoda RC
    Haematologica; 2008 May; 93(5):706-14. PubMed ID: 18367486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche.
    Yoshihara H; Arai F; Hosokawa K; Hagiwara T; Takubo K; Nakamura Y; Gomei Y; Iwasaki H; Matsuoka S; Miyamoto K; Miyazaki H; Takahashi T; Suda T
    Cell Stem Cell; 2007 Dec; 1(6):685-97. PubMed ID: 18371409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.